CClinicalTrials.gg
Status unknownNCT01509014CPATCHUpdated Jan 12, 2012

Community Pharmacy Assisting in Total Cardiovascular Health

An interventional study of CPATCH intervention to support statin adherence in Statin Therapy and Adherence, sponsored by University of Saskatchewan. Status unknown at 1 site in Canada. Per ClinicalTrials.gov, last updated 2012-01-12.

Sponsored by University of Saskatchewan · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Jan 2012), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2,250
Allocation
Randomized
Sex
All
01

Study summary

Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence.

The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.

02

Conditions studied

  • Statin Therapy
  • Adherence

Keywords

  • Statins
  • Adherence
  • Pharmacists
03

In context

Lead sponsor

University of Saskatchewan is the lead sponsor of 237 studies on the registry; 33 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Pharmacies must fill at least 85 statin prescriptions in a six-week period
  • CPATCH intervention was given priority over other study initiatives offered by the pharmacy
  • All members of pharmacy staff provided informed consent
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
2,250 participants (estimated)

Study arms

  • Experimental
    Pharmacy Intervention Arm

    All patients receiving statins from pharmacies allocated to the pharmacist intervention arm of the study

    Behavioral: CPATCH intervention to support statin adherence

  • No intervention
    Usual Care

    Pharmacies not allocated to the intervention arm will serve as the control. They received no training on the CPATCH intervention and provide usual care to patients at their pharmacy.

Interventions

  • BehavioralCPATCH intervention to support statin adherence

    Routine identification of new statin users (first year of therapy), consistent assessment of barriers to adherence at every dispensation for these patients, reassurance about efficacy and safety, and proactive response to identified adherence barriers.

06

What researchers measure

Primary outcomes

  1. Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription

    All statin dispensations are captured by the prescription drug plan database. Mean adherence will be measured using the proportion of days covered (sum of days supply for statin prescriptions during study period divided by the number of days of observation). PDC will be adjusted for any days subject was hospitalized during study period.,

    Time frame: 6 months

Secondary outcomes

  1. Proportion of new statin users with adherence greater than or equal to 80%

    Time frame: 6 months

  2. Persistence with statin use among patients with a minimum of 12 months of follow-up

    Time frame: 6 months

07

Study locations

1 site
  • College of Pharmacy and Nutrition, University of Saskatchewan
    Saskatoon, Saskatchewan S7n 5C9, Canada
08

References and documents

Publications

  • Evans CD, Eurich DT, Taylor JG, Remillard AJ, Shevchuk YM, Blackburn DF. A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study. Trials. 2010 Jul 8;11:76. doi: 10.1186/1745-6215-11-76. PubMed 20615235 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01509014
Lead sponsor
University of Saskatchewan
Collaborators
Ministry of Health, Saskatchewan, Merck Frosst Canada Ltd.
Responsible party
Sponsor
First posted
Jan 12, 2012
Start date
Mar 2010
Primary completion
Nov 2011
Completion
Jan 2012 (estimated)
Last update
Jan 12, 2012

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion